← Insider buys
ALXN

Alexion Pharmaceuticals, Inc.

EVP and Chief Compliance Officer Indrani Lall Franchini sold $308K of Alexion Pharmaceuticals, Inc.

Sold$307,729
$118.13Price
2,605Shares
−8%Stake

What ALXN did after the filing

Prices for ALXN after this filing aren't in yet.

Traded Wed, Nov 28. Filed Fri, Nov 30, 1:15 PM ET, during the session. Not investment advice.